Redcare Pharmacy N.V. — Short Positions & Disclosures
Regulatory net short position disclosures over time
As of 16 Apr 2026, 9 institutions have disclosed net short positions in Redcare Pharmacy N.V. totalling 11.4% of issued share capital. The largest disclosed short seller is D. E. Shaw & Co., L.P. at 3.59%. Positions are publicly disclosed under UK FCA rules once they reach or exceed 0.5% of issued share capital.
Last updated
Redcare Pharmacy N.V. | Short Positions Over Time
NL0012044747Short positions must be disclosed when they reach or exceed 0.5% of issued share capital.
Current Short Positions
All disclosed positions as of the latest report date
| Holder | Net Short % | Position Date | Position Value |
|---|---|---|---|
AHL Partners LLP | 1.22% | 16 Apr 2026 | €9.2m |
D. E. Shaw & Co., L.P. | 3.59% | 16 Apr 2026 | €27m |
PDT Partners, LLC | 0.79% | 16 Apr 2026 | €5.9m |
Two Sigma Investments, LP | 1.30% | 16 Apr 2026 | €9.8m |
BlackRock Investment Management (UK) Limited | 0.59% | 01 Apr 2026 | €4.4m |
Acadian Asset Management LLC | 1.08% | 31 Mar 2026 | €8.1m |
JPMorgan Asset Management (UK) Ltd | 1.58% | 09 Feb 2026 | €11.9m |
Jupiter Asset Management Limited | 0.71% | 11 Nov 2025 | €5.3m |
Arrowstreet Capital, Limited Partnership | 0.59% | 14 Oct 2025 | €4.4m |
Data source: UK Financial Conduct Authority short position disclosures, plus equivalent disclosures from EU regulators (BaFin, CONSOB, AFM, Finansinspektionen). View FCA short selling rules.
Net short percentage represents the percentage of issued share capital held short. Positions must be publicly disclosed when they reach or exceed the 0.5% regulatory threshold. Read the methodology.